Dale Brown: On Giving Your Series a New Direction
Bestselling author Dale Brown explains why he decided to pivot his thriller novel Arctic Storm Rising, which is part of his ongoing Nick Flynn series.
Author:
Flight of the Old Dog (1987) to, most recently,
Eagle Station (2020). A former U.S. Air Force captain, he can often be found flying his own plane in the skies of the United States.
Dale Brown
Arctic Storm Rising, which is part of his ongoing Nick Flynn series, and much more! Take your writing one step further and tackle the publishing process. When you enroll in this online course, you ll learn the details of the query letter format and how to write a query letter that catches the attention of agents and publishers.
Updated 3 hours ago
NBCUniversal, Inc.
Two trials are set to get underway this month at Baylor University Medical Center in Dallas involving treatments that have proven to be highly effective at neutralizing the effects of every known variant of the COVID-19 virus, according to the lead investigator.
The trials use monoclonal antibodies to treat healthy adults who have recently been diagnosed with COVID-19.
Download our NBC DFW mobile app for Apple or Android to get alerts for local breaking news and weather.
“The analogy I would give is if you want to capture a burglar going into your house, capture them while the alarm system is going off, while the burglar is still in the house,” said Robert Gottlieb, MD, Ph.D., who is the lead, principal investigator for Baylor, as well as an advanced heart failure and transplant cardiologist. “With the antibodies, if we get the virus early while the virus is still at high levels, we can help knock it down early, giving your body a hea
Baylor to test new drug against coronavirus variants
The monoclonal antibody neutralizes all known variants of concern, early trials show
Baylor Scott & White Health’s Dallas campus, which includes Baylor University Medical Center.(Baylor Scott & White)
A new treatment that shows promise in fighting coronavirus variants is going into clinical trials in North Texas.
The treatment, a monoclonal antibody from Eli Lilly and Vancouver-based AbCellera Biologics, neutralized all known variants of concern in preliminary lab tests, including variants first identified in the United Kingdom, South Africa, Brazil, California and New York, AbCellera announced Tuesday morning.
“It [attaches to] the virus in a way that allows it to stop every variant that we have currently seen globally,” said AbCellera CEO Carl Hansen in an interview. He added that it also appears capable of neutralizing the so-called double mutant strain found in India.
Как меняется канон svoboda.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from svoboda.org Daily Mail and Mail on Sunday newspapers.